33 results on '"Zhang, Shugeng"'
Search Results
2. Liver Transplantation for Diffuse Form of Caroli Disease with Chronic Hepatitis B: A Case Report
3. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy
4. Adjuvant donafenib for patients with hepatocellular carcinoma at high risk of recurrence following radical resection: A multi-center, retrospective study in China.
5. Cytochrome B5 type A alleviates HCC metastasis via regulating STOML2 related autophagy and promoting sensitivity to ruxolitinib
6. Upregulated mH2A1 serves as an unfavorable prognostic indicator and promotes the progress of hepatocellular carcinoma (HCC)
7. Adjuvant donafenib for hepatocellular carcinoma patients at high-risk of recurrence after radical resection: a real-world experience.
8. Augmented reality navigation for liver resection with a stereoscopic laparoscope
9. A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27
10. LncRNA coordinates Hippo and mTORC1 pathway activation in cancer
11. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways
12. Morphologic Change of In Vivo Porcine Liver Under 13 mm Hg Pneumoperitoneum Pressure
13. ABCA8 is regulated by miR-374b-5p and inhibits proliferation and metastasis of hepatocellular carcinoma through the ERK/ZEB1 pathway
14. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis
15. Data from A PLCB1–PI3K–AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression
16. Supplementary methods from A PLCB1–PI3K–AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression
17. Supplementary Figure S1-S18 from A PLCB1–PI3K–AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression
18. Table S3 from A PLCB1–PI3K–AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression
19. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling
20. Downregulation of MARC2 Promotes Immune Escape and Is Associated With Immunosuppression of Hepatocellular Carcinoma
21. Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer’s Disease and Parkinson’s Disease
22. SKAP2 Promotes Invadopodia Formation in Hepatocellular Carcinoma Through Activating SFKS/JAK1/stat3 Signaling and is Negatively Regulated by miR-193a-3p
23. A PLCB1–PI3K–AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression
24. Inhibition of TGFβ1 accelerates regeneration of fibrotic rat liver elicited by a novel two-staged hepatectomy
25. Clinical characteristics and management of 1572 patients with pyogenic liver abscess: A 12‐year retrospective study
26. A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis
27. Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis
28. Su1076 – Dgat1 Inhibits Epithelial-Mesenchymal Transition-Induced Metastasis of Hepatocellular Carcinoma Via Pi3K/Akt Signaling
29. Clinical characteristics and management of 1572 patients with pyogenic liver abscess: A 12‐year retrospective study.
30. Reduction of hepatic fibrosis by overexpression of von Hippel–Lindau protein in experimental models of chronic liver disease
31. Establishing a New Liver Transplant Unit in China-First Affiliated Hospital of the University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
32. Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer's Disease and Parkinson's Disease.
33. Multi-organ metastasis as destination for breast cancer cells guided by biomechanical architecture.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.